101 related articles for article (PubMed ID: 26272356)
1. Inhibition of 2-methoxyestradiol glucuronidation by probenecid.
Qian Y; Sherbini A; Matin B; Zhao Y; Castellot J; Greenblatt DJ
J Pharm Pharmacol; 2015 Nov; 67(11):1585-92. PubMed ID: 26272356
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol glucuronidation in vitro: potential implications of inhibition by probenecid.
Matin B; Sherbini AA; Alam N; Harmatz JS; Greenblatt DJ
J Pharm Pharmacol; 2019 Mar; 71(3):371-378. PubMed ID: 30417385
[TBL] [Abstract][Full Text] [Related]
3. Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol.
Lakhani NJ; Sparreboom A; Xu X; Veenstra TD; Venitz J; Dahut WL; Figg WD
J Pharm Sci; 2007 Jul; 96(7):1821-31. PubMed ID: 17252610
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol.
Lakhani N; Sparreboom A; Venitz J; Dahut WL; Figg WD
Anticancer Drugs; 2006 Sep; 17(8):977-83. PubMed ID: 16940808
[TBL] [Abstract][Full Text] [Related]
5. Influence of probenecid and paracetamol (acetaminophen) on zidovudine glucuronidation in human liver in vitro.
Kamali F; Rawlins MD
Biopharm Drug Dispos; 1992 Aug; 13(6):403-9. PubMed ID: 1391678
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of in-vitro inhibition of UGT1A1 by paritaprevir.
Alam N; Angeli MG; Greenblatt DJ
J Pharm Pharmacol; 2017 Dec; 69(12):1794-1801. PubMed ID: 28990653
[TBL] [Abstract][Full Text] [Related]
7. Diethylstilbestrol can effectively accelerate estradiol-17-O-glucuronidation, while potently inhibiting estradiol-3-O-glucuronidation.
Zhu L; Xiao L; Xia Y; Zhou K; Wang H; Huang M; Ge G; Wu Y; Wu G; Yang L
Toxicol Appl Pharmacol; 2015 Mar; 283(2):109-16. PubMed ID: 25596428
[TBL] [Abstract][Full Text] [Related]
8. An investigation on intestinal absorption of a new anticancer drug, 2-methoxyestradiol.
Guo XH; Zhang N; Cui FD; Du B; Zhang ZZ
Pharmazie; 2009 Nov; 64(11):748-51. PubMed ID: 20099520
[TBL] [Abstract][Full Text] [Related]
9. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches.
Stevens JC; Fayer JL; Cassidy KC
Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors.
Dahut WL; Lakhani NJ; Gulley JL; Arlen PM; Kohn EC; Kotz H; McNally D; Parr A; Nguyen D; Yang SX; Steinberg SM; Venitz J; Sparreboom A; Figg WD
Cancer Biol Ther; 2006 Jan; 5(1):22-7. PubMed ID: 16357512
[TBL] [Abstract][Full Text] [Related]
11. An orphan esterase ABHD10 modulates probenecid acyl glucuronidation in human liver.
Ito Y; Fukami T; Yokoi T; Nakajima M
Drug Metab Dispos; 2014 Dec; 42(12):2109-16. PubMed ID: 25217485
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of acetaminophen and lorazepam glucuronidation in vitro by probenecid.
von Moltke LL; Manis M; Harmatz JS; Poorman R; Greenblatt DJ
Biopharm Drug Dispos; 1993 Mar; 14(2):119-30. PubMed ID: 8453022
[TBL] [Abstract][Full Text] [Related]
13. Isoflavones modulate the glucuronidation of estradiol in human liver microsomes.
Pfeiffer E; Treiling CR; Hoehle SI; Metzler M
Carcinogenesis; 2005 Dec; 26(12):2172-8. PubMed ID: 16051636
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of 2-methoxyestradiol: new developments.
Mooberry SL
Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
[TBL] [Abstract][Full Text] [Related]
15. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions.
Zhou J; Zhou M; Yang FF; Liu CY; Pan RL; Chang Q; Liu XM; Liao YH
Mol Pharm; 2015 Apr; 12(4):1084-95. PubMed ID: 25723098
[TBL] [Abstract][Full Text] [Related]
17. The effect of probenecid on paracetamol metabolism and pharmacokinetics.
Kamali F
Eur J Clin Pharmacol; 1993; 45(6):551-3. PubMed ID: 8157041
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.
Tevaarwerk AJ; Holen KD; Alberti DB; Sidor C; Arnott J; Quon C; Wilding G; Liu G
Clin Cancer Res; 2009 Feb; 15(4):1460-5. PubMed ID: 19228747
[TBL] [Abstract][Full Text] [Related]
19. Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment.
Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP; van Ewijk-Beneken Kolmer EW
Pharm World Sci; 1994 Feb; 16(1):22-6. PubMed ID: 8156046
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the human kidney to the metabolic clearance of drugs.
Vree TB; Hekster YA; Anderson PG
Ann Pharmacother; 1992 Nov; 26(11):1421-8. PubMed ID: 1477449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
